PTGS2 and staphylococcal infection: In a staphylococcal infection setting, riboflavin has demonstrated its anti-inflammatory property through reductions in NF-κB, COX2 (cyclooxygenase 2), TNF-α, NO, IL-1β (interleukin 1 beta) reducing iNOS (inducible NO synthase) synthesis, as well as an elevation in anti-inflammatory cytokine IL-10 (interleukin 10), and modulation of MCP-1 (monocyte chemoattractant protein 1) function, a potent chemoattractant (34).